Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Dual-target CAR T-celtherapie vertraagt groei glioblastoom
okt 2025 | Neuro-oncologie